➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Dow
Moodys
McKesson
Express Scripts
McKinsey

Last Updated: June 20, 2021

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 077273


Email this page to a colleague

« Back to Dashboard

NDA 077273 describes TUSSICAPS, which is a drug marketed by Ecr Pharma and is included in one NDA. It is available from one supplier. Additional details are available on the TUSSICAPS profile page.

The generic ingredient in TUSSICAPS is chlorpheniramine polistirex; hydrocodone polistirex. There are twenty-nine drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the chlorpheniramine polistirex; hydrocodone polistirex profile page.
Summary for 077273
Pharmacology for NDA: 077273
Suppliers and Packaging for NDA: 077273
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TUSSICAPS chlorpheniramine polistirex; hydrocodone polistirex CAPSULE, EXTENDED RELEASE;ORAL 077273 ANDA Bausch Health US LLC 0187-0108 0187-0108-01 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0187-0108-01)
TUSSICAPS chlorpheniramine polistirex; hydrocodone polistirex CAPSULE, EXTENDED RELEASE;ORAL 077273 ANDA Bausch Health US LLC 0187-0108 0187-0108-20 20 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0187-0108-20)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE, EXTENDED RELEASE;ORALStrengthEQ 8MG MALEATE;EQ 10MG BITARTRATE
Approval Date:Sep 24, 2007TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE, EXTENDED RELEASE;ORALStrengthEQ 4MG MALEATE;EQ 5MG BITARTRATE
Approval Date:Sep 24, 2007TE:RLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Medtronic
Express Scripts
Dow
AstraZeneca
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.